|

Liposomal doxorubicin containing regimen Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

  • Postoperative Adjuvant Treatment1
  • Liposomal Doxorubicin1
  • Safety1
  • Efficacy1
  • Breast Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.